NCT05711940
ClinicalTrials.gov
- Trial ID
- T-ctgov-NCT05711940
- Registry
- ClinicalTrials.gov
- NCT number
- NCT05711940
- Asset
- COMP360
- Sponsor, as registered
- COMPASS Pathways
- Phase
- PHASE3
- Indication
- Treatment Resistant Depression
- Status
- ACTIVE_NOT_RECRUITING
- Start date
- 2023-02-14
- Primary completion
- 2025-11-13
- Registered countries
- Canada, Czechia, Denmark, France, Germany, Ireland, Netherlands, Poland, Spain, Sweden, United Kingdom, United States
- Sites
- 116
The sponsor's registered location list, which states intent rather than approval.
clinicaltrials.govctgov registryverified 2026-08-31
Notes on the record
Fields read from the ClinicalTrials.gov v2 API record. countries is the distinct country list across all registered locations; site_count is the number of location entries, which counts a country once per site, not once per country.
Company
Through COMP360: Compass Pathways
Cited in
Issues quoting NCT05711940 in their own text.